<DOC>
	<DOCNO>NCT02761993</DOCNO>
	<brief_summary>The purpose study determine whether ST266 reduce pocket depth ( PD ) adjunctive scale root planing ( SRP ) subject moderate severe periodontal disease .</brief_summary>
	<brief_title>Safety , Efficacy Treatment Regimen Study ST266 Subjects With Moderate Severe Periodontitis</brief_title>
	<detailed_description>The study 9-month , randomize , double-blind , parallel-design study subject exist moderate severe periodontal disease randomly assign one three group . The primary endpoint PD change evaluate follow 3 month treatment . Subjects follow 9 month safety radiographic evaluation . Subjects meet inclusion criterion randomize one three treatment group . Randomization stratify site smoker status ( never smoke quit smoke two year ago vs. smoke within last two year ) . Randomization block assignment treatment group within site within smoker status approximately even ( 1:1:1 ) . Treatment initiate scale root planing ( SRP ) . All subject evaluate baseline Days 1 , 15 , 30 , 60 , 90 , 180 , 270 .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>Provision sign , write informed consent prior participation studyrelated procedure . Good general health evidence medical history . Between 18 85 year age time inform consent signature . Male female . Minimum 18 teeth , exclude third molar . Having moderate severe periodontal disease accord AAP definition ( least 6 teeth ≥6 mm PD ≥3 mm CAL baseline ) . Having &gt; 30 percent bleeding sit upon probe . Willing abstain chew gum mouth rinse study duration . Ability willingness attend study visit comply study visit comply study procedure requirement . Willingness abstain routine dental care . For woman reproductive potential , willingness use highly effective contraception ( e.g . license hormonal contraception , intrauterine device , abstinence , vasectomy partner ) . Presence orthodontic appliance . A soft hard tissue tumor oral cavity . Any dental condition require immediate treatment , carious lesion . Participation clinical study within 30 day screen study . Pregnancy lactation . If subject meet criterion , may rescreened study participation long meet criterion . Antibiotic therapy within last 30 day . Chronic use ( ≥3 times/week ) antiinflammatory medication ( e.g. , nonsteroidal anti inflammatory drug , steroid ) . Lowdose aspirin ( le 325 mg daily ) allow . Immunocompromised subject . Subjects cancer history cancer within last 5 year screen . Any medical history concomitant medication might affect assessment study treatment periodontal tissue , diabetes , nifedipine , phenytoin ( Dilantin ) , anticoagulant medication ( e.g. , warfarin [ Coumadin ] etc. ) . Involvement plan conduct study . History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , interfere interpretation subject 's study result . Previous randomization treatment present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>